Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

Chlamydia pneumoniae

P J Cook1, D Honeybourne

  • 1Department of Thoracic Medicine, Dudley Road Hospital, Birmingham, UK.

The Journal of Antimicrobial Chemotherapy
|December 1, 1994
PubMed
Summary
This summary is machine-generated.

Chlamydia pneumoniae causes pneumonia and is linked to heart disease. Diagnosis is challenging, relying on methods like PCR and serology, with treatment and vaccination also reviewed.

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Diagnostic and prognostic significance of systemic alkyl quinolones for P. aeruginosa in cystic fibrosis: A longitudinal study; response to comments.

Journal of cystic fibrosis : official journal of the European Cystic Fibrosis Society·2017
Same author

Magneto-optical stokes polarimetry and nanostructured magnetic materials.

Journal of nanoscience and nanotechnology·2012
Same author

Microbial contamination of non-invasive ventilation devices used by adults with cystic fibrosis.

The Journal of hospital infection·2012
Same author

Long-term impact of liver transplantation on respiratory function and nutritional status in children and adults with cystic fibrosis.

American journal of transplantation : official journal of the American Society of Transplantation and the American Society of Transplant Surgeons·2012
Same author

Renal impairment in cystic fibrosis.

Thorax·2008
Same author

Concentrations in plasma, epithelial lining fluid, alveolar macrophages and bronchial mucosa after a single intravenous dose of 1.6 mg/kg of iclaprim (AR-100) in healthy men.

The Journal of antimicrobial chemotherapy·2007
Same journal

Favipiravir tissue distribution and inhibitory quotients in preclinical models: towards a pipeline for evidence-based antiviral repurposing.

The Journal of antimicrobial chemotherapy·2026
Same journal

A review of the randomized clinical trial results from the Staphylococcus aureus network adaptive platform (SNAP) meticillin-susceptible (MSSA) and penicillin-susceptible (PSSA) domains and CloCeBa.

The Journal of antimicrobial chemotherapy·2026
Same journal

Incidence and factors associated with subtherapeutic cefazolin levels among patients with severe infections.

The Journal of antimicrobial chemotherapy·2026
Same journal

Emerging resistance in staphylococci following long-term dalbavancin treatment for prosthetic joint infections.

The Journal of antimicrobial chemotherapy·2026
Same journal

Microbiology testing around the time of antibiotic initiation among residents of long-term care facilities.

The Journal of antimicrobial chemotherapy·2026
Same journal

Insights into the mechanisms underlying cell wall-active agents and gentamicin bactericidal synergism against Enterococcus faecalis.

The Journal of antimicrobial chemotherapy·2026
See all related articles

Area of Science:

  • Microbiology
  • Infectious Diseases
  • Cardiology

Background:

  • Chlamydia pneumoniae is a significant human pathogen responsible for community-acquired and nosocomial pneumonias worldwide.
  • This bacterium presents with diverse clinical manifestations and has been implicated in ischemic heart disease.
  • Accurate diagnosis is hindered by the difficulty in isolating Chlamydia pneumoniae via traditional cell culture methods.

Purpose of the Study:

  • To review diagnostic techniques for Chlamydia pneumoniae infections.
  • To discuss the clinical presentations and associations of Chlamydia pneumoniae, including its link to ischemic heart disease.
  • To explore current treatment options and the potential for vaccination against Chlamydia pneumoniae.

Main Methods:

  • Cell culture limitations for Chlamydia pneumoniae isolation.

Related Experiment Videos

  • Antigen detection methods: direct immunofluorescence and enzyme immunoassay.
  • Serological techniques, including micro-immunofluorescence.
  • Molecular diagnostics: polymerase chain reaction (PCR).

    • Main Results:

    • Chlamydia pneumoniae is a prevalent global infectious agent.
    • Various diagnostic methods have specific challenges and advantages.
    • Association with ischemic heart disease warrants further investigation.
    • Current treatments and vaccination strategies are under consideration.

    Conclusions:

    • Effective diagnosis of Chlamydia pneumoniae relies on a combination of advanced techniques beyond cell culture.
    • Understanding the diverse clinical spectrum and associated conditions like heart disease is crucial.
    • Ongoing research into treatments and vaccines is vital for controlling Chlamydia pneumoniae infections.